Cellectar Biosciences, Inc. Resources
News & Media
Investors
Contact
Cellectar Biosciences, Inc.
Home
About
Overview
Partnerships
Management Team
Board of Directors
Technology
Overview
Posters & Publications
Product Pipeline
Overview
CLR 131
Clinical Trials
Overview
Relapsed or Refractory Multiple Myeloma Clinical Trial
Recruiting
Children With Relapsed or Refractory Malignant Cancer Clinical Trial
Recruiting
Relapsed or Refractory Select B-Cell Malignancies Clinical Trial
Recruiting
News & Media
Investors
Contact
Presentations
News & Media
News & Media
Press Releases
Presentations
Events
Corporate Presentation
Jan 13, 2020
Fact Sheet
Oct 31, 2019
